Class 3 Medicines Recall: Azacitidine 100 Mg/vial And 150 Mg/vial Powder For Suspension For Injection, El(25)a/08
Recall Summary Accord Healthcare Limited is recalling specific batches of Azacitidine 100 mg/vial and 150 mg/vial powder for injection in the United Kingdom. The recall is precautionary due to higher-than-acceptable levels of a related impurity (compound C) found during stability testing. This medication is used to treat certain blood cancers and related conditions.
- Recalling firm
- Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection
- Reason
- Accord Healthcare Limited is recalling certain batches of Azacitidine Powder for Suspension for Injection 100 mg/vial and 150 mg/vial as precautionary measure due to out of specification results for Azacitidine related compound C impurity during stability testing.
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2025-03-03
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/c8c2ad06-e779-4d44-90b8-e99088636c5b